Discovery of cGAS-like signaling enzymes in innate immunity and disease
Project Number1DP2GM146250-01
Former Number1DP2OD030985-01
Contact PI/Project LeaderKRANZUSCH, PHILIP J
Awardee OrganizationDANA-FARBER CANCER INST
Description
Abstract Text
Project Summary
Human cells use signals called "RNA second messengers" to stimulate the immune response and prevent
disease. These signals are produced in response to pathogen infection and cellular stress, and are important for
controlling cellular communication. Recent evidence demonstrates that RNA second messenger signaling
controlled by the enzyme cyclic GMP–AMP synthase (cGAS) is a critical component of the immune response to
many types of cancer, and drug analogues developed from these natural signals are rapidly emerging as
promising new treatments. The potent antitumor potential of these drugs illustrates the importance of discovery
and mechanistic understanding of naturally occurring RNA second messenger signals.
Surprisingly, our work has revealed that cGAS is part of a broad family of signaling enzymes we named
cGAS/DncV-like nucleotidyltransferase (CD-NTase) enzymes, and many RNA second messenger pathways
remain to be discovered in human biology. Potential human CD-NTases include uncharacterized immune cGAS-
like receptors previously implicated as genes frequently mutated in cancer. Our results demonstrate that RNA
second messenger signaling pathways are a new rich area of research and likely impact many areas of basic
human biology and disease. We have developed an innovative approach to uncover the function of these
enzymes and discover the biology and natural products responsible for signaling.
Our proposed research will provide a new detailed understanding of the enzymes that control RNA second
messenger signaling and enable discovery of entirely new classes of RNA signals. Specifically, the proposed
experiments will use kingdom-wide analysis of CD-NTase enzymes to determine the mechanism of specific RNA
product synthesis, X-ray crystallography to define the structural and molecular basis of metazoan CD-NTase
function, and an innovative set of cell biology experiments using newly identified CD-NTase RNA signals for
direct cell stimulation and chemical-proteomics. Our experiments will define the function of newly discovered
cGAS-like enzymes in human biology and explain the molecular rules that allow RNA second messengers to
control downstream cellular responses.
Public Health Relevance Statement
Project Narrative
Human cells use signals called “RNA second messengers” to stimulate the immune response, control cancer,
and guide correct tissue development. Surprisingly, our work has revealed that the best characterized gene
known to activate RNA second messenger signaling is part of a broad family of signaling enzymes and many
RNA second messenger pathways remain to be discovered. We have developed an innovative approach to
uncover the function of these enzymes and provide a detailed understanding of how RNA second messengers
can be harnessed to improve immune responses and prevent disease.
No Sub Projects information available for 1DP2GM146250-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1DP2GM146250-01
Patents
No Patents information available for 1DP2GM146250-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1DP2GM146250-01
Clinical Studies
No Clinical Studies information available for 1DP2GM146250-01
News and More
Related News Releases
No news release information available for 1DP2GM146250-01
History
No Historical information available for 1DP2GM146250-01
Similar Projects
No Similar Projects information available for 1DP2GM146250-01